MSB 2.17% $1.13 mesoblast limited

$5.8 Billion, page-42

  1. 30,333 Posts.
    lightbulb Created with Sketch. 1837
    I think that ethics, patient safety and costs are the reasons that we have got fast tracking from the FDA.

    We already have a manufacturing facility, so ramping up production will be something they have in place to go ahead as soon as the green light from FDA is received. Teva won't be wanting delays before return on their investment. MSB won't want them either.

    Ethanol? Arguably it has a bad effect on cells and mutation. There is a link between regular drinking, and high alcohol comsumption and cancer. Overuse of mouthwashes with ethanol in them = higher incidence of mouth cancer. I can't see them conducting large scale clinical trials to establish these links conclusively. Just take note and live simply.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.